A Randomized Controlled Trial to Evaluate the Efficacy of Whole Body Vibration on Walking Performance in Elderly Hemodialysis Patients

Osaka University1 site in 1 country98 target enrollmentApril 1, 2021

ConditionsHemodialysis

Overview

Phase: N/A
Intervention: Not specified
Conditions: Hemodialysis
Sponsor: Osaka University
Enrollment: 98
Locations: 1
Primary Endpoint: Change in the timed up and go test
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to evaluate the efficacy of whole body vibration for 12 weeks on walking performance in elderly hemodialysis patients.

Detailed Description

This is a multicenter, prospective, randomized controlled trial. Eligible subjects will be randomized in a 1:1 ratio to a whole-body vibration (WBV) group or controlled group. Patients in a WBV group will receive WBV training three times a week before initiation of dialysis sessions for 12 weeks. The primary outcome of the study will be the change in walking performance assessed by the timed up and go test.

Registry

clinicaltrials.gov

Start Date

April 1, 2021

End Date

March 30, 2022

Last Updated

3 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Osaka University

Responsible Party

Principal Investigator

Yusuke Sakaguchi

assistant professor

Osaka University

Eligibility Criteria

Inclusion Criteria

•Undergoing maintenance hemodialysis three times a week .

Exclusion Criteria

•Having difficulty in walking by oneself.
•Having difficulty in receiving whole body vibration training because of cognitive impairment.
•History of fracture of lower limb within 1 year.
•History of total hip arthroplasty.
•Unsuitable for participant in the trial by an attending physician.